The UK Veterinary Vaccinology Network is happy to announce the funding of up to five prestigious registration scholarships for Early Career Researchers to attend the Keystone Symposia "Translational Vaccinology for Human Health", October 25-29, 2016, Park Plaza Riverbank, London, United Kingdom.
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
The Translational Vaccinology for Human Health Keystone Symposium has a prestigious line-up of vaccinology research speakers from around the world. These awarded scholarships will provide early career vaccinologists the opportunity to network and participate in a world-leading conference in vaccinology. Due to the focus of human health in the conference, scholarship awardees will be expected to be veterinary research ambassadors highlighting the importance of veterinary vaccinology to translational medicine; awarded scholarships will be based on an abstract application which will be highlighted in the poster sessions and the organisers of the conference may also invite exceptional applications to present their research in the 'Short talks chose from abstracts' section of the programme.
Scholarship awardees will be asked to write a critical analysis of the impact the meeting has had on their own research.
- Controlled Human Infection Models
- Workshop 1: Correlates of Protection
- Human Immune Profiling
- Toward PK/PD in B cell Vaccinology
- Workshop 2: Human Immunophenotyping
- Novel Appraoches to Antigen Identification and Immunogen Design
- Adjuvants, Mucosal and Otherwise
- Clinical Trial Readouts
- Workshop 3: Antigen Identification, Adjuvants, Formulations and Novel Delivery Platforms
- Accelerating Global Health Vaccine R&D
What the Scholarship will include:
The scholarship will cover the registration fees for the awardee to attend the Keystone Symposium. It will not cover travel or any other expenses.
Who can apply:
The scholarships are eligible for early career veterinary vaccine researchers currently working towards a PhD or having completed a PhD in the last five years. Career breaks will also be considered (please note this on application).
Applying:
Please provide a covering letter including research interests, institute affiliation,contact details, what stage you are in your career and how specifically attending the conference will aid your career development.
Please also submit an abstract in a separate document, following the guidelines below.
Abstract format:
- NO email addresses, phone numbers, hyperlinks, keyword lists, comments, text or image boxes.
- Paragraph breaks between Title, Author & Institute, abstract body, funding and references
- File must be saved as Rich Text File format (RTF)
- 2200 characters count including spaces. Also includes title, authors, affiliations, references and funding.
- Arial, 11 point, black font
- Single spacing, one inch margins, left justified
- One abstract per submitting author per meeting. Submitting author and account name must match. Submitting author must be underlined.
Abstract example
Criteria for Abstract Review:
In submitting your abstract please consider:
- Relevance to the meeting topics
- Significance of the scientific question and results
- Style: Organization (e.g., the abstract has a clear beginning, middle and end), Grammar and spelling
- Clarity of scientific presentations:
- Clear question or hypothesis
- Sufficient background
- The experimental approach and rationale for the approach are clear
- The results are clearly presented
- The interpretation and conclusions are reasonable and logical
Deadline:
Please email all applications to enquiries@vetvaccnet.ac.uk by the 26th July 2016
Keystone Translational Vaccinology for Human Health Flyer.pdf
